4xjr: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==The catalytic mechanism of human parainfluenza virus type 3 haemagglutinin-neuraminidase revealed== | ==The catalytic mechanism of human parainfluenza virus type 3 haemagglutinin-neuraminidase revealed== | ||
<StructureSection load='4xjr' size='340' side='right' caption='[[4xjr]], [[Resolution|resolution]] 3.00Å' scene=''> | <StructureSection load='4xjr' size='340' side='right'caption='[[4xjr]], [[Resolution|resolution]] 3.00Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[4xjr]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4XJR OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4XJR FirstGlance]. <br> | <table><tr><td colspan='2'>[[4xjr]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Hpiv-3 Hpiv-3]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4XJR OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4XJR FirstGlance]. <br> | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=OEL:(6R)-2,6-ANHYDRO-3,4,5-TRIDEOXY-6-[(2S)-2,3-DIHYDROXYPROPANOYL]-3-FLUORO-5-[(2-METHYLPROPANOYL)AMINO]-4-TRIAZA-1,2-DIEN-2-IUM-1-YL-L-GULONIC+ACID'>OEL</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=OEL:(6R)-2,6-ANHYDRO-3,4,5-TRIDEOXY-6-[(2S)-2,3-DIHYDROXYPROPANOYL]-3-FLUORO-5-[(2-METHYLPROPANOYL)AMINO]-4-TRIAZA-1,2-DIEN-2-IUM-1-YL-L-GULONIC+ACID'>OEL</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4xjq|4xjq]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4xjq|4xjq]]</td></tr> | ||
| Line 18: | Line 18: | ||
</div> | </div> | ||
<div class="pdbe-citations 4xjr" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 4xjr" style="background-color:#fffaf0;"></div> | ||
==See Also== | |||
*[[Hemagglutinin|Hemagglutinin]] | |||
== References == | == References == | ||
<references/> | <references/> | ||
| Line 23: | Line 26: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Exo-alpha-sialidase]] | [[Category: Exo-alpha-sialidase]] | ||
[[Category: Hpiv-3]] | |||
[[Category: Large Structures]] | |||
[[Category: Carroux, C]] | [[Category: Carroux, C]] | ||
[[Category: Chavas, L]] | [[Category: Chavas, L]] | ||
Revision as of 10:44, 29 May 2019
The catalytic mechanism of human parainfluenza virus type 3 haemagglutinin-neuraminidase revealedThe catalytic mechanism of human parainfluenza virus type 3 haemagglutinin-neuraminidase revealed
Structural highlights
Publication Abstract from PubMedHuman parainfluenza virus type 3 (hPIV-3) is one of the leading causes for lower respiratory tract disease in children, with neither an approved antiviral drug nor vaccine available to date. Understanding the catalytic mechanism of human parainfluenza virus haemagglutinin-neuraminidase (HN) protein is key to the design of specific inhibitors against this virus. Herein, we used (1) H NMR spectroscopy, X-ray crystallography, and virological assays to study the catalytic mechanism of the HN enzyme activity and have identified the conserved Tyr530 as a key amino acid involved in catalysis. A novel 2,3-difluorosialic acid derivative showed prolonged enzyme inhibition and was found to react and form a covalent bond with Tyr530. Furthermore, the novel derivative exhibited enhanced potency in virus blockade assays relative to its Neu2en analogue. These outcomes open the door for a new generation of potent inhibitors against hPIV-3 HN. The catalytic mechanism of human parainfluenza virus type 3 haemagglutinin-neuraminidase revealed.,Dirr L, El-Deeb IM, Guillon P, Carroux CJ, Chavas LM, von Itzstein M Angew Chem Int Ed Engl. 2015 Mar 2;54(10):2936-40. doi: 10.1002/anie.201412243., Epub 2015 Feb 10. PMID:25676091[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
|
| ||||||||||||||||||||